World Journal of Diabetes,
Journal Year:
2024,
Volume and Issue:
15(12), P. 2399 - 2403
Published: Nov. 14, 2024
Diabetic
osteoporosis
(DOP)
is
a
serious
complication
of
diabetes
mellitus.
It
urgent
to
explore
efficient
clinical
treatment
strategies
for
DOP.
has
been
found
that
mesenchymal
stem
cell-derived
extracellular
vesicles
(MSC-EVs),
as
an
emerging
cell-free
therapy,
show
great
potential
in
DOP
treatment.
MSC-EVs
can
effectively
promote
bone
formation,
inhibit
resorption,
and
modulate
the
inflammatory
microenvironment
by
delivering
cargoes
microRNAs,
long
non-coding
RNAs,
proteins
target
cells,
thereby
ameliorating
loss
However,
there
are
limited
reports
on
with
MSC-EVs.
To
evoke
more
attention
this
strategy,
article
summarised
extant
literature
provide
new
directions
further
research
application
management